British trainer John Gosden is feeling let down by the British Horseracing Authority (BHA) after his disqualification from the Group 2 British Champions Long Distance Cup in October. The BHA ordered the disqualification following the discovery of the anti-inflammatory Triamcinolone Acetonide (TCA) in a pre-race sample of Royal Line, according to the Racing Post, which led to the horse being stripped of his third place finish in the race.
There is a mandatory 14-day stand-down period for TCA, but the BHA has warned that that stand-down period may be shorter than the actual withdrawal period. Gosden's Royal Line received 15 milligrams of Adcortyl, containing TCA, in both hind fetlocks to reduce inflammation 17 days prior to the race, which was confirmed by vet reports. Gosden accepted the results of the positive test, but wanted to make it clear there was no foul play involved.
“I'm very conservative with my use of any medication and the horse's welfare is paramount,” Gosden told racingpost.com. “I followed all guidelines and advice and the negative publicity from this matter reflects badly on the trainer, the highly respected Newmarket Equine Hospital practice and inevitably damages the image of racing. I feel exceptionally let down by this process.”
Gosden proposed that the BHA give more help on the matter and attempt to educate other horsemen to avoid more situations such as this one. He was fined £1,000 (about US$1,200) and his horse was disqualified.
Read more at racingpost.com.
The post Gosden Feels ‘Let Down’ By BHA After Positive Test Leads To Disqualification appeared first on Horse Racing News | Paulick Report.
